Chongqing Precision Biotech Co., Ltd.

Cn
En

INNOVATION FOR HEALTH

BUILD A GLOBAL AND INNOVATIVE BIOPHARMACEUTICAL ENTERPRISE

Production technology platform

Basic research and development platform

Planning to build Chongqing Regional Cell Preparation Center

ABOUT US

18000_㎡

IND and NDA Platforms For Cell-based Drug

159₊

R&D Elite

10₊

Pipeline

4

Class I New Drugs

9

Indication

43

Patents

CORPORATE
CULTURE

MANAGEMENT
TEAM

PIPELINE

R&D PLATFORM

CORE TECHNOLOGY

MANUFACTURING

NEWS & INFORMATION

The Groundbreaking Ceremony for Chongqing Precision Biotech Cell Technology Research and Development Center and Cell Preparation Center Was Successfully Completed

On November 8, 2024, the groundbreaking ceremony for Chongqing Precision Biotech Cell Technology R&D and Cell Preparation Center project was held in the Western Science City, Chongqing High-tech Zone.

Delegation from Kimbiri of Peru and the President of Tashkent Pharmaceutical University Visited Chongqing Precision Biotech

Delegation from Kimbiri of Peru and the President of Tashkent Pharmaceutical University Visited Chongqing Precision Biotech

Exclusive Interview with Professor Qian Cheng, Chairman of Precision Biotech: Successfully Broken through the CAR-T Track, and the First Domestic CAR-T cell Drug for Pediatric Leukemia Is about to Be Approved

Exclusive Interview with Professor Qian Cheng, Chairman of Precision Biotech: Successfully Broken through the CAR-T Track, and the First Domestic CAR-T cell Drug for Pediatric Leukemia Is about to Be Approved

Chongqing Precision Biotech’s First IND Application for CAR-T therapy in Autoimmune Diseases has been Accepted by CDE

Exclusive Interview with Professor Qian Cheng, Chairman of Precision Biotech: Successfully Broken through the CAR-T Track, and the First Domestic CAR-T cell Drug for Pediatric Leukemia Is about to Be Approved

FOLLOW US ON WECHAT

© Copyright 2016-2024 重庆精准生物技术有限公司 All Rights Reserved

渝ICP备16003030号-1

渝公网安备 50010702505019号

Design By:zhiing